288 related articles for article (PubMed ID: 19277361)
1. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy.
Brevet D; Gary-Bobo M; Raehm L; Richeter S; Hocine O; Amro K; Loock B; Couleaud P; Frochot C; Morère A; Maillard P; Garcia M; Durand JO
Chem Commun (Camb); 2009 Mar; (12):1475-7. PubMed ID: 19277361
[TBL] [Abstract][Full Text] [Related]
2. Silicalites and Mesoporous Silica Nanoparticles for photodynamic therapy.
Hocine O; Gary-Bobo M; Brevet D; Maynadier M; Fontanel S; Raehm L; Richeter S; Loock B; Couleaud P; Frochot C; Charnay C; Derrien G; Smaïhi M; Sahmoune A; Morère A; Maillard P; Garcia M; Durand JO
Int J Pharm; 2010 Dec; 402(1-2):221-30. PubMed ID: 20934496
[TBL] [Abstract][Full Text] [Related]
3. Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors.
Gary-Bobo M; Mir Y; Rouxel C; Brevet D; Basile I; Maynadier M; Vaillant O; Mongin O; Blanchard-Desce M; Morère A; Garcia M; Durand JO; Raehm L
Angew Chem Int Ed Engl; 2011 Nov; 50(48):11425-9. PubMed ID: 21976357
[No Abstract] [Full Text] [Related]
4. Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy.
Gary-Bobo M; Mir Y; Rouxel C; Brevet D; Hocine O; Maynadier M; Gallud A; Da Silva A; Mongin O; Blanchard-Desce M; Richeter S; Loock B; Maillard P; Morère A; Garcia M; Raehm L; Durand JO
Int J Pharm; 2012 Aug; 432(1-2):99-104. PubMed ID: 22569231
[TBL] [Abstract][Full Text] [Related]
5. Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery.
Park IY; Kim IY; Yoo MK; Choi YJ; Cho MH; Cho CS
Int J Pharm; 2008 Jul; 359(1-2):280-7. PubMed ID: 18490119
[TBL] [Abstract][Full Text] [Related]
6. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers.
Yang Y; Song W; Wang A; Zhu P; Fei J; Li J
Phys Chem Chem Phys; 2010 May; 12(17):4418-22. PubMed ID: 20407714
[TBL] [Abstract][Full Text] [Related]
7. Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT.
Gary-Bobo M; Hocine O; Brevet D; Maynadier M; Raehm L; Richeter S; Charasson V; Loock B; Morère A; Maillard P; Garcia M; Durand JO
Int J Pharm; 2012 Feb; 423(2):509-15. PubMed ID: 22178618
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of mannose receptor mediated macrophage targeting delivery system.
Zhu L; Chen L; Cao QR; Chen D; Cui J
J Control Release; 2011 Nov; 152 Suppl 1():e190-1. PubMed ID: 22195844
[No Abstract] [Full Text] [Related]
9. Small mesoporous silica nanoparticles as carriers for enhanced photodynamic therapy.
Zhu J; Wang H; Liao L; Zhao L; Zhou L; Yu M; Wang Y; Liu B; Yu C
Chem Asian J; 2011 Sep; 6(9):2332-8. PubMed ID: 21744503
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-functionalized mesoporous silica nanoparticles for efficient photodynamic therapy of cancer cells.
Gary-Bobo M; Brevet D; Benkirane-Jessel N; Raehm L; Maillard P; Garcia M; Durand JO
Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):256-60. PubMed ID: 22959805
[TBL] [Abstract][Full Text] [Related]
11. Mannosyl-coated nanocomplexes from amphiphilic cyclodextrins and pDNA for site-specific gene delivery.
Díaz-Moscoso A; Guilloteau N; Bienvenu C; Méndez-Ardoy A; Blanco JL; Benito JM; Le Gourriérec L; Di Giorgio C; Vierling P; Defaye J; Mellet CO; Fernández JM
Biomaterials; 2011 Oct; 32(29):7263-73. PubMed ID: 21741082
[TBL] [Abstract][Full Text] [Related]
12. Specific interaction of mannosylated glycopolymers with macrophage cells mediated by mannose receptor.
Park KH; Sung WJ; Kim S; Kim DH; Akaike T; Chung HM
J Biosci Bioeng; 2005 Mar; 99(3):285-9. PubMed ID: 16233790
[TBL] [Abstract][Full Text] [Related]
13. Silica-based nanoparticles for photodynamic therapy applications.
Couleaud P; Morosini V; Frochot C; Richeter S; Raehm L; Durand JO
Nanoscale; 2010 Jul; 2(7):1083-95. PubMed ID: 20648332
[TBL] [Abstract][Full Text] [Related]
14. Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors.
Rosenholm JM; Peuhu E; Bate-Eya LT; Eriksson JE; Sahlgren C; Lindén M
Small; 2010 Jun; 6(11):1234-41. PubMed ID: 20486218
[TBL] [Abstract][Full Text] [Related]
15. A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery.
Park HS; Kim CW; Lee HJ; Choi JH; Lee SG; Yun YP; Kwon IC; Lee SJ; Jeong SY; Lee SC
Nanotechnology; 2010 Jun; 21(22):225101. PubMed ID: 20453291
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of mannosylated oligoribonucleotides.
Zhao Y; Tram K; Yan H
Carbohydr Res; 2009 Nov; 344(16):2137-43. PubMed ID: 19765694
[TBL] [Abstract][Full Text] [Related]
17. Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one- or two-photon process.
Lin Q; Huang Q; Li C; Bao C; Liu Z; Li F; Zhu L
J Am Chem Soc; 2010 Aug; 132(31):10645-7. PubMed ID: 20681684
[TBL] [Abstract][Full Text] [Related]
18. Mesoporous-silica-coated up-conversion fluorescent nanoparticles for photodynamic therapy.
Qian HS; Guo HC; Ho PC; Mahendran R; Zhang Y
Small; 2009 Oct; 5(20):2285-90. PubMed ID: 19598161
[TBL] [Abstract][Full Text] [Related]
19. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells.
Slowing I; Trewyn BG; Lin VS
J Am Chem Soc; 2006 Nov; 128(46):14792-3. PubMed ID: 17105274
[TBL] [Abstract][Full Text] [Related]
20. Targeting of porous hybrid silica nanoparticles to cancer cells.
Rosenholm JM; Meinander A; Peuhu E; Niemi R; Eriksson JE; Sahlgren C; Lindén M
ACS Nano; 2009 Jan; 3(1):197-206. PubMed ID: 19206267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
